| Natalie Huntington Vaughn, MD | |
|
1 Medical Park Blvd Ste 300e, Bristol, TN 37620-7497 | |
| (423) 844-6450 | |
| (423) 844-6499 |
| Full Name | Natalie Huntington Vaughn |
|---|---|
| Gender | Female |
| Speciality | Orthopedic Surgery |
| Experience | 10 Years |
| Location | 1 Medical Park Blvd Ste 300e, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093133845 | NPI | - | NPPES |
| Q060872 | Medicaid | TN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 60461 (Tennessee) | Secondary |
| 207X00000X | Orthopaedic Surgery | 0101268476 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Carilion Medical Center | Roanoke, VA | Hospital |
| Carilion Franklin Memorial Hospital | Rocky mount, VA | Hospital |
| Carilion New River Valley Medical Center | Christiansburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carilion Medical Center | 9830096585 | 758 |
News Archive
Cipher Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately severe chronic pain in adults.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
In a study published yesterday in the journal Neurobiology of Aging, researchers have reported that aged chimpanzees may show similar if not identical brain changes as persons with early Alzheimer's disease. Chimpanzees are the closes linked animals with humans and these findings may help understand the mechanism of development of Alzheimer's disease believe researchers.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago
| Entity Name | Carilion Healthcare Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447206370 PECOS PAC ID: 5890607253 Enrollment ID: O20031106000273 |
News Archive
Cipher Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately severe chronic pain in adults.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
In a study published yesterday in the journal Neurobiology of Aging, researchers have reported that aged chimpanzees may show similar if not identical brain changes as persons with early Alzheimer's disease. Chimpanzees are the closes linked animals with humans and these findings may help understand the mechanism of development of Alzheimer's disease believe researchers.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago
| Entity Name | Carilion Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730123472 PECOS PAC ID: 9830096585 Enrollment ID: O20040107000472 |
News Archive
Cipher Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately severe chronic pain in adults.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
In a study published yesterday in the journal Neurobiology of Aging, researchers have reported that aged chimpanzees may show similar if not identical brain changes as persons with early Alzheimer's disease. Chimpanzees are the closes linked animals with humans and these findings may help understand the mechanism of development of Alzheimer's disease believe researchers.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago
| Entity Name | Abingdon Physician Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306944350 PECOS PAC ID: 5991705667 Enrollment ID: O20070102000365 |
News Archive
Cipher Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately severe chronic pain in adults.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
In a study published yesterday in the journal Neurobiology of Aging, researchers have reported that aged chimpanzees may show similar if not identical brain changes as persons with early Alzheimer's disease. Chimpanzees are the closes linked animals with humans and these findings may help understand the mechanism of development of Alzheimer's disease believe researchers.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Natalie Huntington Vaughn, MD 213 S Jefferson St Ste 1006, Roanoke, VA 24011-1713 Ph: () - | Natalie Huntington Vaughn, MD 1 Medical Park Blvd Ste 300e, Bristol, TN 37620-7497 Ph: (423) 844-6450 |
News Archive
Cipher Pharmaceuticals Inc. today announced the U.S. Food and Drug Administration has approved CIP-TRAMADOL ER, the Company's extended-release tramadol product, for the treatment of moderate to moderately severe chronic pain in adults.
The latest episode in the American Chemical Society's (ACS') award-winning Global Challenges/Chemistry Solutions podcast series describes a potential new approach for treating urinary tract infections (UTIs) - which affect millions of people annually - without traditional antibiotics. Because it involves non-antibiotic compounds, the approach would not contribute to the growing problem of antibiotic-resistant bacteria, or "superbugs."
In a study published yesterday in the journal Neurobiology of Aging, researchers have reported that aged chimpanzees may show similar if not identical brain changes as persons with early Alzheimer's disease. Chimpanzees are the closes linked animals with humans and these findings may help understand the mechanism of development of Alzheimer's disease believe researchers.
A new study indicates that rituximab is more effective than fingolimod for preventing relapses in patients with highly active multiple sclerosis switching from treatment with natalizumab.
› Verified 6 days ago
Dr. Bert E Tagert, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 1 Medical Park Blvd, Ste 300 E, Bristol, TN 37620 Phone: 423-844-6450 Fax: 423-844-6499 | |
Tyler M Duncan, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-280-9011 Fax: 423-282-0035 | |
Dr. Michael R Fleenor, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 260 Midway Medical Park, Ste 100, Bristol, TN 37620 Phone: 423-968-4446 Fax: 423-968-4802 | |
Dr. Richard Andrew Hillesheim, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 | |
Jonathan D Bryant, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 | |
Dr. Jason Allen Fogleman, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 340 Steeles Rd, Bristol, TN 37620 Phone: 423-282-9011 Fax: 423-282-0035 |